COVID-19 and multiorgan failure: A narrative review on potential mechanisms

T Mokhtari, F Hassani, N Ghaffari, B Ebrahimi… - Journal of molecular …, 2020 - Springer
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …

Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers

Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study

Á Romero-Duarte, M Rivera-Izquierdo… - BMC medicine, 2021 - Springer
Background Long-term effects of COVID-19, also called Long COVID, affect more than 10%
of patients. The most severe cases (ie those requiring hospitalization) present a higher …

Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients

DL Silva, CM Lima, VCR Magalhães… - Journal of Hospital …, 2021 - Elsevier
Background SARS-CoV-2 predisposes patients to secondary infections; however, a better
understanding of the impact of coinfections on the outcome of hospitalized COVID-19 …

Hematologic disorders associated with COVID-19: a review

MS Rahi, V Jindal, SP Reyes, K Gunasekaran… - Annals of …, 2021 - Springer
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2.
Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem …

Non-respiratory presentations of COVID-19, a clinical review

M AlSamman, A Caggiula, S Ganguli, M Misak… - The American journal of …, 2020 - Elsevier
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
is a highly infectious viral syndrome currently threatening millions of people worldwide. It is …

[HTML][HTML] Biomarkers for prognosis and treatment response in COVID-19 patients

G Bivona, L Agnello, M Ciaccio - Annals of laboratory …, 2021 - synapse.koreamed.org
During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost
all analytes can change, presenting a correlation with disease severity and survival; …

Bacterial coinfections increase mortality of severely ill COVID-19 patients in Saudi Arabia

A Alqahtani, E Alamer, M Mir, A Alasmari… - International journal of …, 2022 - mdpi.com
Coronavirus disease 19 (COVID-19) is an ongoing global pandemic that is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The severity and mortality …

[HTML][HTML] COVID-19: Review and hematologic impact

SL de Oliveira Toledo, LS Nogueira… - Clinica Chimica …, 2020 - Elsevier
In the last decades, coronaviruses have been a major threat to public health worldwide.
SARS-CoV-2 is the third known coronavirus that causes fatal respiratory diseases in …

COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics

AP Spihlman, N Gadi, SC Wu, VR Moulton - Frontiers in Immunology, 2020 - frontiersin.org
The SARS-CoV-2 novel coronavirus has caused the COVID-19 pandemic with over 35
million cases and over a million deaths worldwide as of early October 2020. The populations …